Your session is about to expire
← Back to Search
Cyclosporine Eye Drops for Dry Eye Syndrome
Study Summary
This trial will evaluate the effectiveness of a new, higher concentration cyclosporine eye drop in treating dry eye, compared to the current standard of care.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have any eye diseases other than Dry Eye.You have been diagnosed with Dry Eye, but you haven't been given a prescription for any medication to treat it.You have significant difficulties with your eyes, as indicated by a score higher than 12 on a special test called OSDI.You have been diagnosed with Dry Eye and are currently taking Cequa.
- Group 1: Cyclosporine + Artificial Tears
- Group 2: Artificial Tears
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the FDA given clearance to Artificial tear for consumer use?
"The safety of artificial tear has been thoroughly assessed, thus receiving a score of 3. Such a high rating is attributed to this being an FDA-approved phase 4 trial."
Are applications presently being accepted for this scientific experiment?
"This experiment is no longer recruiting patients, in spite of having been posted on the clinicaltrials.gov website on November 1st 2022 and last modified September 7th 2022. Nevertheless, there are 149 medical trials currently accepting memberships into their studies."
What other empirical investigations involving Artificial tear have been conducted?
"Currently, there are 67 trials in progress examining the potential of Artificial tear. 12 of these investigations have reached Phase 3 and most originate from Aurora, Colorado. However, across 470 separate medical sites around the world, this drug is being tested for safety and efficacy."
How many participants is the trial accommodating?
"Sadly, this trial is no longer recruiting. The first post was on November 1st 2022 and the study's last edit occured on September 7th 2022. If you are searching for other medical trials related to dry eyes or artifical tears, there are currently 82 studies and 67 studies respectively that are still accepting participants."
In what contexts is artificial tear regularly employed?
"Artificial tear is often the most effective course of action for treating transplantation. There are also various other maladies that may benefit from artificial tear, including lupus nephritis, bulla and excessive tearing."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger